Stimcell Energetics (STME) Free Cash Flow (QoQ) (2011 - 2026)
Stimcell Energetics (STME) Free Cash Flow (QoQ) (2011 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.46 Bn | 193.86 Bn | 7.27 Bn |
| 2 | Stryker | 127.41 Bn | 123.93 Bn | 4.50 Bn |
| 3 | Medtronic | 118.87 Bn | 109.65 Bn | 6.41 Bn |
| 4 | Boston Scientific | 73.47 Bn | 72.93 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 51.95 Bn | 47.69 Bn | 1.35 Bn |
| 6 | Dexcom | 34.30 Bn | 32.35 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 33.76 Bn | 31.65 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.35 Bn | 23.02 Bn | 4.55 Bn |
| 9 | Steris | 23.04 Bn | 22.55 Bn | 684.20 Mn |
| 10 | Stimcell Energetics | 4.65 Mn | 4.64 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Feb 28, 2026 | -16.39% |
| Nov 30, 2025 | 31.44% |
| Aug 31, 2025 | -85.02% |
| May 31, 2025 | -33.70% |
| Feb 28, 2025 | -164.64% |
| Nov 30, 2024 | 27.92% |
| Aug 31, 2024 | 28.98% |
| May 31, 2024 | 14.96% |
| Feb 29, 2024 | -7.41% |
| Nov 30, 2023 | 12.46% |
| Aug 31, 2023 | -57.50% |
| May 31, 2023 | 75.21% |
| Feb 28, 2023 | -52.98% |
| Nov 30, 2022 | 10.69% |
| Aug 31, 2022 | 20.01% |
| May 31, 2022 | -7.76% |
| Feb 28, 2022 | 24.94% |
| Nov 30, 2021 | 22.73% |
| Aug 31, 2021 | -2.30% |
| May 31, 2021 | -49.81% |